Teva Probe Reveals 'Likely' FCPA Transgressions
Generic-pharma giant Teva Pharmaceutical Industries Ltd.'s three-year internal investigation of Foreign Corrupt Practices Act issues has unearthed probable violations on three continents, the company said on Tuesday....To view the full article, register now.
Already a subscriber? Click here to view full article